Every finding on record at Hp Hospice Care Inc

Upon patient record review, 5 of 14 (Patient 1, 2, 4, 8 and 13) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient 1 medication profile includes “Meclizine 25 mg tab 1 tab orally prn as needed for dizziness” with no clear frequency and “Voltaren 1% topical gel, apply twice daily as needed for mild pain” with no location identified. Patient 2 medication profile includes “Voltaren 1% topical gel, apply prn as needed for pain” with no location and no clear frequency identified and “Nitroglycerin 0.4mg tab 1 tab sublingual as needed for chest pain” with no dosage instructions and no dosage limit. Patient 4 medication profile includes “Albuterol Sulfate 90 mcg 2 puffs inhalation prn” with no clear frequency and “Lantus 100u/ml SC daily at night” with no dosage indicated. Patient 8 medication profile includes “Voltaren 1% topical gel apply twice daily as needed for pain” with no location identified and medication profile also includes “Diclofenac Sodium 1% topical gel twice daily prn pain”; duplicative therapy. Patient 13 medication profile includes “Diclofenac Sodium 1.5% topical gel three times daily as needed for pain” with no location identified.

Upon patient record review, 5 of 14 (Patient 1, 2, 4, 8 and 13) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. Patient 1 plan of care includes “Meclizine 25 mg tab 1 tab orally prn as needed for dizziness” with no clear frequency and “Voltaren 1% topical gel, apply twice daily as needed for mild pain” with no location identified. Patient 2 plan of care includes “Voltaren 1% topical gel, apply prn as needed for pain” with no location and no clear frequency identified and “Nitroglycerin 0.4mg tab 1 tab sublingual as needed for chest pain” with no dosage instructions and no dosage limit. Patient 4 plan of care includes “Albuterol Sulfate 90 mcg 2 puffs inhalation prn” with no clear frequency and “Lantus 100u/ml SC daily at night” with no dosage indicated. Patient 8 plan of care includes “Voltaren 1% topical gel apply twice daily as needed for pain” with no location identified and medication profile also includes “Diclofenac Sodium 1% topical gel twice daily prn pain”; duplicative therapy. Patient 13 plan of care includes “Diclofenac Sodium 1.5% topical gel three times daily as needed for pain” with no location identified.